ATE116320T1 - 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids. - Google Patents

5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids.

Info

Publication number
ATE116320T1
ATE116320T1 AT90107099T AT90107099T ATE116320T1 AT E116320 T1 ATE116320 T1 AT E116320T1 AT 90107099 T AT90107099 T AT 90107099T AT 90107099 T AT90107099 T AT 90107099T AT E116320 T1 ATE116320 T1 AT E116320T1
Authority
AT
Austria
Prior art keywords
pyrido
dihydro
aids
treatment
thione
Prior art date
Application number
AT90107099T
Other languages
English (en)
Inventor
Karl D Dr Hargrave
Guenther Dr Schmidt
Wolfhard Dr Engel
Volkhard Dr Austel
Original Assignee
Boehringer Ingelheim Pharma
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Thomae Gmbh Dr K filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of ATE116320T1 publication Critical patent/ATE116320T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT90107099T 1989-04-20 1990-04-12 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids. ATE116320T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34093789A 1989-04-20 1989-04-20
US37272889A 1989-06-28 1989-06-28
US43892289A 1989-11-17 1989-11-17

Publications (1)

Publication Number Publication Date
ATE116320T1 true ATE116320T1 (de) 1995-01-15

Family

ID=27407433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90107099T ATE116320T1 (de) 1989-04-20 1990-04-12 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids.

Country Status (8)

Country Link
EP (1) EP0393530B1 (de)
JP (1) JP2911956B2 (de)
AT (1) ATE116320T1 (de)
CA (1) CA2014884C (de)
DE (1) DE69015411T2 (de)
DK (1) DK0393530T3 (de)
ES (1) ES2066897T3 (de)
GR (1) GR3015469T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475231A1 (de) * 1990-09-10 1992-03-18 F. Hoffmann-La Roche Ag Benzodiazepine
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
WO1994017075A1 (en) * 1993-01-20 1994-08-04 A. Menarini Industrie Farmaceutiche Riunite S.R.L. Diazepin derivatives and antiviral compositions
US6593337B1 (en) 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1542160A (fr) * 1966-10-31 1968-10-11 Thomae Gmbh Dr K Procédé de fabrication de nouvelles 5, 11-dihydro-6h-pyrido-[2, 3-b] [1, 4]-benzodiazépine-6-ones substituées en position 11

Also Published As

Publication number Publication date
DK0393530T3 (da) 1995-05-22
GR3015469T3 (en) 1995-06-30
DE69015411D1 (de) 1995-02-09
CA2014884C (en) 1999-09-07
JPH0363275A (ja) 1991-03-19
EP0393530A1 (de) 1990-10-24
DE69015411T2 (de) 1995-05-24
JP2911956B2 (ja) 1999-06-28
EP0393530B1 (de) 1994-12-28
ES2066897T3 (es) 1995-03-16
CA2014884A1 (en) 1990-10-20

Similar Documents

Publication Publication Date Title
DE19975051I2 (de) 5,11-Dihydro-6H-dipyrido(3,2-b:2'3'-e)(1,4)diazepine und ihre Verwendung zur Verhinderung oder Behandlung von HIV-Infektionen.
ZA917744B (en) Fused ring analogs of nitrogen containing nonaromatic heterocycles.
ES2078440T3 (es) Compuestos farmaceuticos.
MY103352A (en) Piperazinyl-heterocyclic compounds
DE69710490T2 (de) Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente
DE69626915D1 (de) 8-Arylalkyl- und 8-Arylheteroalkyl-5, 11-dihydro-6H-dipyrido-(3,2-b:2', 3'-e)(1,4)diazepine und ihre Verwendung zur Vorbeugung oder Behandlung von HIV-Infektion
ATE316529T1 (de) Substituierte pyridylmethylpiperazin- und piperidinderivate, deren herstellung und deren verwendung in der behandlung von erkrankungen des zentralnervensystems (zns)
ATE103918T1 (de) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'e>(1,4>diazepin-6-one und -thione und ihre verwendung bei der aids-vorbeugung oder behandlung.
DE68925004T2 (de) Verwendung von 2,3,4,5-Tetrahydro-1H-3-Benzazepinen bei der Behandlung von neurologischen Störungen.
FI945000A (fi) Menetelmä (S)-amino-1-substituoitujen pyrrolidiinien valmistamiseksi
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
ATE116320T1 (de) 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids.
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE69213777D1 (de) Pyridobenzodiazepine, Dipyrido-[3,2-b:2',3'-3] [1,4]-diazepine und deren Verwendung in der Vorbeugung und Behandlung von AIDS
MY104090A (en) Thaz derivatives for enhancement of cerebral function.
PH24501A (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
ATE137239T1 (de) Thienopyrazin-2,3-dione verwendbar bei der behandlung von zns-störungen, und ihre herstellung.
MX9604346A (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido [3,2-b :2',3'-e] [1,4]diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee